ロード中...
CDK8-Novel Therapeutic Opportunities
Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target...
保存先:
| 出版年: | Pharmaceuticals (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6630639/ https://ncbi.nlm.nih.gov/pubmed/31248103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph12020092 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|